1968Tumori JournalRequires access

Chemotheraphy of Medulloblastoma

Mario V. Fiorentino, R Vangelista

Open publisher page 2 citations

Abstract

A combination of Vincristine, Cyclophosphamide and intrathecal Methotrexate has proved effective in obtaining a remission of a recurrent medulloblastoma metastatized to the spinal cord of a 5 years old boy. The remission has been lasting 4 months, before treatment switched again to radiotherapy.

About this research paper

What this paper is about

A combination of Vincristine, Cyclophosphamide and intrathecal Methotrexate has proved effective in obtaining a remission of a recurrent medulloblastoma metastatized to the spinal cord of a 5 years old boy. The remission has been lasting 4 months, before treatment switched again to radiotherapy.

Why it matters

OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

A combination of Vincristine, Cyclophosphamide and intrathecal Methotrexate has proved effective in obtaining a remission of a recurrent medulloblastoma metastatized to the spinal cord of a 5 years old boy. The remission has been lasting 4 months, before treatment switched again to radiotherapy.

Key concepts: Medulloblastoma, Vincristine, Cyclophosphamide, Methotrexate, Medicine, Radiation therapy, Spinal cord, Complete remission

Related papers

Back to paper searchBrowse research topicsOriginal source
Chemotheraphy of Medulloblastoma — Research Paper | ScholarLens